Literature DB >> 21766071

The 'mystery' of opioid-induced diarrhea.

Silviu Bril1, Yoav Shoham, Jeremy Marcus.   

Abstract

Bowel dysfunction, mainly constipation, is a well-known and anticipated side effect of opioids. The physician prescribing an opioid frequently confronts the challenge of preventing and treating bowel dysfunction. Different strategies have emerged for managing opioid-induced constipation. These strategies include physical activity, maintaining adequate fluid intake, adhering to regular daily bowel habits, using laxatives and other anticonstipation medications and, recently, using a peripheral opioid antagonist, either as a separate drug or in the form of an opioid agonistantagonist combination pill. What options exist for the physician when a patient receiving opioids complains of diarrhea, cramps and bloating, rather than the expected constipation? The present article describes a possible cause of opioid-induced diarrhea and strategies for management.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21766071      PMCID: PMC3198112          DOI: 10.1155/2011/309685

Source DB:  PubMed          Journal:  Pain Res Manag        ISSN: 1203-6765            Impact factor:   3.037


  26 in total

Review 1.  Palliative care pharmacotherapy literature summaries and analyses.

Authors:  Amy P Abernethy
Journal:  J Pain Palliat Care Pharmacother       Date:  2009

2.  Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial.

Authors:  O Löwenstein; P Leyendecker; M Hopp; U Schutter; P D Rogers; R Uhl; S Bond; W Kremers; T Nichols; B Krain; K Reimer
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

Review 3.  Incidence, prevalence, and management of opioid bowel dysfunction.

Authors:  M Pappagallo
Journal:  Am J Surg       Date:  2001-11       Impact factor: 2.565

4.  Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey.

Authors:  Timothy Bell; Kathy Annunziata; John B Leslie
Journal:  J Opioid Manag       Date:  2009 May-Jun

Review 5.  Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management.

Authors:  Peter Holzer; Sam H Ahmedzai; Norbert Niederle; Petra Leyendecker; Michael Hopp; Björn Bosse; Ingrid Spohr; Karen Reimer
Journal:  J Opioid Manag       Date:  2009 May-Jun

Review 6.  Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.

Authors:  Karen Reimer; Michael Hopp; Michael Zenz; Christoph Maier; Peter Holzer; Gerd Mikus; Bjoern Bosse; Kevin Smith; Catharina Buschmann-Kramm; Petra Leyendecker
Journal:  Pharmacology       Date:  2008-10-28       Impact factor: 2.547

Review 7.  Lactose intolerance: a non-allergic disorder often managed by allergologists.

Authors:  A Perino; S Cabras; D Obinu; L Cavalli Sforza
Journal:  Eur Ann Allergy Clin Immunol       Date:  2009-02

8.  A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.

Authors:  Winfried Meissner; Petra Leyendecker; Stefan Mueller-Lissner; Joachim Nadstawek; Michael Hopp; Christian Ruckes; Stefan Wirz; Wolfgang Fleischer; Karen Reimer
Journal:  Eur J Pain       Date:  2008-08-31       Impact factor: 3.931

9.  Quantifying the 'hidden' lactose in drugs used for the treatment of gastrointestinal conditions.

Authors:  P Eadala; J P Waud; S B Matthews; J T Green; A K Campbell
Journal:  Aliment Pharmacol Ther       Date:  2009-03-15       Impact factor: 8.171

10.  Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy.

Authors:  Sean D Candrilli; Keith L Davis; Shrividya Iyer
Journal:  J Pain Palliat Care Pharmacother       Date:  2009
View more
  4 in total

Review 1.  Evolving paradigms in the treatment of opioid-induced bowel dysfunction.

Authors:  Jakob Lykke Poulsen; Christina Brock; Anne Estrup Olesen; Matias Nilsson; Asbjørn Mohr Drewes
Journal:  Therap Adv Gastroenterol       Date:  2015-11       Impact factor: 4.409

Review 2.  Opioid-induced bowel dysfunction: pathophysiology and management.

Authors:  Christina Brock; Søren Schou Olesen; Anne Estrup Olesen; Jens Brøndum Frøkjaer; Trine Andresen; Asbjørn Mohr Drewes
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

Review 3.  Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction.

Authors:  Jakob Lykke Poulsen; Christina Brock; Anne Estrup Olesen; Matias Nilsson; Asbjørn Mohr Drewes
Journal:  Clin Exp Gastroenterol       Date:  2014-09-19

Review 4.  A review of the clinical manifestations, pathophysiology and management of opioid bowel dysfunction and narcotic bowel syndrome.

Authors:  Zahra Azizi; Sanam Javid Anbardan; Naser Ebrahimi Daryani
Journal:  Middle East J Dig Dis       Date:  2014-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.